The Potential Value of Ongoing Support In Type-1 Diabetes Mellitus With Dafneplus- Exploratory Pre-Trial Cost-Effectiveness Analysis On Proposed Trial End-Point Target For 12-Month Hba1c Improvement
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.725
https://www.valueinhealthjournal.com/article/S1098-3015(14)02655-2/fulltext
Section Title :
Disease-Specific Studies
Section Order :
149
First Page :
A350
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02655-2&doi=10.1016/j.jval.2014.08.725